I
JANX icon

InceptionR’s Janux Therapeutics JANX Stock Holding History

InceptionR’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Buy
+18,273
New +$265K 0.07% 490
2025
Q4 		– Sell
-10,010
Closed -$245K – 733
2025
Q3 		$245K Buy
+10,010
New +$244K 0.06% 534

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

InceptionR's JANX Position: Q2 2026 in Review

InceptionR opened a new position in Janux Therapeutics (JANX) in Q2 2026: 18,273 shares worth $281K. The stake represents 0.07% of the portfolio and ranks #490 among its holdings. This is a return to the name: InceptionR previously reported a position in JANX as recently as Q3 2025.

InceptionR first reported a position in JANX in Q3 2025 and has held it in 2 quarters since. 198 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • InceptionR held 18,273 shares of Janux Therapeutics worth $281K as of Q2 2026.
  • Janux Therapeutics was a new InceptionR position in Q2 2026.
  • Janux Therapeutics made up 0.07% of InceptionR's portfolio in Q2 2026, its #490 holding.
  • InceptionR first reported a position in Janux Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 198 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.